Isocitrate Dehydrogenase Mutations in Myelodysplastic Syndromes and in Acute Myeloid Leukemias
Acute myeloid leukemia (AML) is a heterogeneous disease generated by the acquisition of multiple genetic and epigenetic aberrations which impair the proliferation and differentiation of hematopoietic progenitors and precursors. In the last years, there has been a dramatic improvement in the understa...
Main Authors: | Ugo Testa, Germana Castelli, Elvira Pelosi |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-08-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/12/9/2427 |
Similar Items
-
Molecular alterations of isocitrate dehydrogenase 1 and 2 (<it>IDH1 </it>and <it>IDH2</it>) metabolic genes and additional genetic mutations in newly diagnosed acute myeloid leukemia patients
by: Chotirat Sadudee, et al.
Published: (2012-03-01) -
(2<i>R</i>,3<i>S</i>)-Dihydroxybutanoic Acid Synthesis as a Novel Metabolic Function of Mutant Isocitrate Dehydrogenase 1 and 2 in Acute Myeloid Leukemia
by: Jeffrey R. Idle, et al.
Published: (2020-10-01) -
Mutant Isocitrate Dehydrogenase Inhibitors as Targeted Cancer Therapeutics
by: Danielle Golub, et al.
Published: (2019-05-01) -
Screening of Methylation Signature and Gene Functions Associated With the Subtypes of Isocitrate Dehydrogenase-Mutation Gliomas
by: XiaoYong Pan, et al.
Published: (2019-11-01) -
Mutation of Isocitrate Dehydrogenase 1 in Cholangiocarcinoma Impairs Tumor Progression by Inhibiting Isocitrate Metabolism
by: Li Su, et al.
Published: (2020-04-01)